chr14-50757395-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_020921.4(NIN):c.3635C>T(p.Ala1212Val) variant causes a missense change. The variant allele was found at a frequency of 0.000026 in 1,614,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. A1212A) has been classified as Likely benign.
Frequency
Consequence
NM_020921.4 missense
Scores
Clinical Significance
Conservation
Publications
- Seckel syndrome 7Inheritance: AR, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_020921.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NIN | NM_020921.4 | MANE Select | c.3635C>T | p.Ala1212Val | missense | Exon 18 of 31 | NP_065972.4 | ||
| NIN | NM_182946.2 | c.3635C>T | p.Ala1212Val | missense | Exon 18 of 30 | NP_891991.2 | |||
| NIN | NM_182944.3 | c.3635C>T | p.Ala1212Val | missense | Exon 18 of 30 | NP_891989.3 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NIN | ENST00000530997.7 | TSL:5 MANE Select | c.3635C>T | p.Ala1212Val | missense | Exon 18 of 31 | ENSP00000436092.2 | ||
| NIN | ENST00000382041.7 | TSL:1 | c.3635C>T | p.Ala1212Val | missense | Exon 18 of 30 | ENSP00000371472.3 | ||
| NIN | ENST00000382043.8 | TSL:1 | c.2399+2462C>T | intron | N/A | ENSP00000371474.4 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152092Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 251362 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461868Hom.: 0 Cov.: 63 AF XY: 0.0000234 AC XY: 17AN XY: 727236 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152210Hom.: 0 Cov.: 31 AF XY: 0.0000134 AC XY: 1AN XY: 74422 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 377176). This variant has not been reported in the literature in individuals affected with NIN-related conditions. This variant is present in population databases (rs548569136, gnomAD 0.004%). This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1212 of the NIN protein (p.Ala1212Val). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
not specified Uncertain:1
The c.3635C>T (p.A1212V) alteration is located in exon 18 (coding exon 16) of the NIN gene. This alteration results from a C to T substitution at nucleotide position 3635, causing the alanine (A) at amino acid position 1212 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at